Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 31 January 2012 and unaudited. Performance at month end with net income reinvested One Three One Three Since launch Month Months Year Years (20 Sep 04) Net asset value* (Undiluted) 4.8% 0.6% -13.5% 49.1% 103.0% Net asset value* (Diluted) 4.8% 0.6% -11.6% 49.2% 103.1% Share price 6.2% -1.6% -13.2% 42.1% 93.9% FTSE World Europe ex UK 4.3% -0.5% -13.5% 30.9% 64.1% Sources: BlackRock and Datastream * Net asset value and share price performance includes the subscription share reinvestment, assuming the subscription share entitlement per share was sold and the proceeds reinvested on the first day of trading. At month end Net asset value (capital only): 175.98p Net asset value (including income): 175.98p Net asset value (capital only)**: 175.98p Net asset value (including income)**: 175.98p Share price: 173.25p Discount to NAV (including income): 1.6% Subscription share price: 7.50p Gearing: Nil Net yield: 2.1% Total assets: £167.0m Ordinary shares in issue: 94,873,100*** Subscription shares in issue: 18,342,725 ** Diluted for subscription shares. *** Excluding 2,734,952 shares held in treasury. Benchmark Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%) Consumer Goods 23.6 18.7 Switzerland 22.0 Health Care 16.9 11.7 Germany 14.5 Industrials 16.1 15.0 France 13.5 Financials 15.4 19.8 Netherlands 10.1 Consumer Services 9.1 5.2 Denmark 5.6 Oil & Gas 7.6 7.4 Sweden 3.8 Basic Materials 6.0 8.2 Spain 3.6 Technology 2.7 3.5 Italy 3.5 Utilities 1.6 5.2 Norway 3.2 Telecommunications 1.0 5.3 Belgium 2.9 Net current assets - - Ireland 2.7 ----- ----- Luxembourg 2.6 100.0 100.0 Finland 2.4 ===== ===== Portugal 2.2 Russia 1.8 Czech Republic 1.6 Other 4.0 Net current assets - ----- 100.0 ===== Ten Largest Equity Investments (in alphabetical order) Company Country of Risk Ahold Netherlands Allianz Germany Danone France ENI Italy LVMH France Nestlé Switzerland Novo Nordisk Denmark Pernod Ricard France Roche Switzerland Syngenta Switzerland Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: Market Equity markets delivered positive returns in January. The tentative rally we saw in Q4 has broadened out from high quality international companies to riskier cyclicals including the financials sector. Risk appetite returned in January, supported by improving global growth prospects, progress in the European sovereign debt crisis and looser monetary policy. The ECB's long term refinancing operations (LTRO) provided much needed liquidity in the bond market and Italian and Spanish bond yields fell back to around 5% and 6% respectively. Global leading indicators rebounded and Euro flash PMIs recovered above the 50-threshold indicating tentative signs of expansion, while German IFO was stronger than expected. Fund Performance & Attribution During the month the Company's NAV rose by 4.8% and the share price by 6.2%. For reference, the FTSE World Europe ex UK Index was up 4.3% during the same period. Stock selection was a key driver to performance, whilst sector allocation was marginally negative. January saw a reallocation back into risk assets and, as a result, the portfolio benefited from lower weightings within the more defensive telecoms and utilities sectors which performed less well than the market. Accurate stock selection within the health care sector proved successful, primarily as a result of not owning some defensive large cap pharmaceuticals stocks which lagged the rally such as Novartis and Sanofi. A lower weighting in the financials sector detracted from returns as banks received some respite from their poor performance during the previous two quarters. However, a selective approach aided performance and positions in OTP, GAM and Allianz were amongst the top contributors. Other top performers included budget airline Ryanair which announced strong results and which is well positioned to benefit from consolidation within the European airline industry. On a less positive note, defensive consumer-related stocks were out of favour where investors took profits and a number of names detracted from performance. These included food producers Danone and Nestlé, food retailer Ahold, brewer Anheuser-Busch InBev and spirit producer Pernod Ricard. During the month, the Company decreased its consumer goods exposure through the sale of the holding in Elringklinger and BMW and by selling out of cosmetic company L'Oreal. Within financials, the Company increased its weighting mainly by initiating a new position in Sberbank and by adding to existing holdings GAM and Allianz. At the end of the month, the Company had higher weightings (when compared with the FTSE World Europe ex UK Index) in health care, consumer goods, consumer services, industrials and oil & gas and lower weightings in financials, telecoms, utilities, basic materials and technology. Outlook Moving into 2012, progress towards a resolution of the European sovereign debt issues will continue to shape investor sentiment and markets are likely to remain volatile. Investors are, however, pricing in a significant risk premium for the current political and economic uncertainties and we believe our strategy of building positions in the long term winners, companies with highly differentiated business models, strong balance sheets and structural growth driven largely by international demand, will deliver attractive returns over the medium term. 21 February 2012 ENDS Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings